These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2188122)

  • 1. Age-related DNA modifications (I-compounds): modulation by physiological and pathological processes.
    Randerath K; Li DH; Randerath E
    Mutat Res; 1990 May; 238(3):245-53. PubMed ID: 2188122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K; Randerath E
    Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous and endogenous DNA modifications as monitored by 32P-postlabeling: relationships to cancer and aging.
    Randerath K; Li D; Nath R; Randerath E
    Exp Gerontol; 1992; 27(5-6):533-49. PubMed ID: 1426086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between diet and age-related DNA modifications (I-compounds) in rat liver and kidney.
    Li DH; Randerath K
    Cancer Res; 1990 Jul; 50(13):3991-6. PubMed ID: 2354447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent covalent DNA alterations (I-compounds) in rodent tissues: species, tissue and sex specificities.
    Randerath K; Liehr JG; Gladek A; Randerath E
    Mutat Res; 1989 Mar; 219(2):121-33. PubMed ID: 2927417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of I-compounds in DNA from a spectrum of Morris hepatomas.
    Randerath K; Randerath E; Danna TF
    Carcinogenesis; 1990 Jun; 11(6):1041-4. PubMed ID: 2347063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural dietary ingredients (oats and alfalfa) induce covalent DNA modifications (I-compounds) in rat liver and kidney.
    Li D; Chen S; Randerath K
    Nutr Cancer; 1992; 17(3):205-16. PubMed ID: 1437640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between different types of covalent DNA modifications (I-compounds, persistent carcinogen adducts and 5-methylcytosine) in regenerating rat liver.
    Randerath K; Lu LJ; Li D
    Carcinogenesis; 1988 Oct; 9(10):1843-8. PubMed ID: 3168163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent covalent DNA alterations (I-compounds) in rat liver mitochondrial DNA.
    Gupta KP; van Golen KL; Randerath E; Randerath K
    Mutat Res; 1990 Jan; 237(1):17-27. PubMed ID: 2320036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of DNA modification (I-compound) levels in rat liver and kidney by dietary carbohydrate, protein, fat, vitamin, and mineral content.
    Li D; Randerath K
    Mutat Res; 1992 Jan; 275(1):47-56. PubMed ID: 1372687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ-specific effects of long term feeding of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,7,8-pentachlorodibenzo-p-dioxin on I-compounds in hepatic and renal DNA of female Sprague-Dawley rats.
    Randerath K; Putman KL; Randerath E; Mason G; Kelley M; Safe S
    Carcinogenesis; 1988 Dec; 9(12):2285-9. PubMed ID: 3191574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced accumulation of I-compounds in liver DNA of rats fed a choline-devoid diet.
    Li D; Chandar N; Lombardi B; Randerath K
    Carcinogenesis; 1989 Mar; 10(3):605-7. PubMed ID: 2924404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oat lipids-induced covalent DNA modifications (I-compounds) in female Sprague-Dawley rats, as determined by 32P-postlabeling.
    Li D; Chen S; Randerath E; Randerath K
    Chem Biol Interact; 1992 Nov; 84(3):229-42. PubMed ID: 1423742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
    Randerath K; Randerath E; Danna TF; van Golen L; Putman KL
    Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bulky endogenous DNA modifications (I-compounds) -possible structural origins and functional implications.
    Randerath K; Randerath E; Zhou GD; Li D
    Mutat Res; 1999 Mar; 424(1-2):183-94. PubMed ID: 10064860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age- and tissue-related DNA modifications in untreated rats: detection by 32P-postlabeling assay and possible significance for spontaneous tumor induction and aging.
    Randerath K; Reddy MV; Disher RM
    Carcinogenesis; 1986 Sep; 7(9):1615-7. PubMed ID: 3742734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of rat liver DNA alterations by chronic administration of peroxisome proliferators as detected by 32P-postlabeling.
    Randerath E; Randerath K; Reddy R; Danna TF; Rao MS; Reddy JK
    Mutat Res; 1991 Mar; 247(1):65-76. PubMed ID: 2002806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
    Reddy MV; Randerath K
    Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.